SCHEMBL3376517

SCHEMBL3376517

CC(C)(Cn1ccc(C(N)=O)n1)OC[C@H](O)CNC(CO)CO

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 5/20 0.31
ADRB3 P13945 4/20 0.31
TDP1 Q9NUW8 3/20 0.31
LMNA P02545 2/20 0.31
KDM4E B2RXH2 2/20 0.31
ADRB2 P07550 2/20 0.31
CNR1 P21554 1/20 0.31
ADRA1D P25100 1/20 0.31
ADRA1A P35348 1/20 0.31
ADRA1B P35368 1/20 0.31
CYP1A2 P05177 1/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
THPO P40225 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373893 0.88 ALDH1A1 (0.32) LMNACYP1A2MEN1ALDH1A1KMT2A
SCHEMBL3375209 0.87 ADRB2 (0.34) ADRB1ADRB3KDM4EADRB2MEN1
SCHEMBL3434243 0.87 ADRB2 (0.34) ADRB1ADRB3KDM4EADRB2MEN1
SCHEMBL3376519 0.85 KDM4E (0.31) ADRB1ADRB3KDM4EADRB2
SCHEMBL3375856 0.84 MEN1 (0.33) MEN1KMT2ASMN1; SMN2
SCHEMBL3375011 0.83 ALDH1A1 (0.32) CYP1A2MEN1ALDH1A1KMT2A
SCHEMBL3373631 0.83 ALDH1A1 (0.32) CYP1A2MEN1ALDH1A1KMT2A
SCHEMBL14556269 0.81 HIF1A (0.36) ADRB1ADRB3LMNAADRB2ALDH1A1
SCHEMBL3373628 0.81 HIF1A (0.36) ADRB1ADRB3LMNAADRB2ALDH1A1
SCHEMBL3373895 0.71 ALDH1A1 (0.33) TDP1LMNAKDM4ECYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354444-B2 Substituted pyrrolidine-2-carboxamides HOFFMANN-LA ROCHE INC. (US) 2013-01-15 US claimed
EP-2340021-B1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES HOFFMANN LA ROCHE (CH) 2012-11-07 EP claimed
US-20100152190-A1 Substituted Pyrrolidine-2-Carboxamides F. HOFFMANN-LA ROCHE AG (CH) 2010-06-17 US claimed
US-20100075948-A1 Substituted Pyrrolidine-2-Carboxamides DING QINGJIE 2010-03-25 US claimed
EP-2534132-B1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES HOFFMANN LA ROCHE (CH) 2017-04-26 EP disclosed
US-8354444-B2 Substituted pyrrolidine-2-carboxamides HOFFMANN-LA ROCHE INC. (US) 2013-01-15 US disclosed
EP-2340021-B1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES HOFFMANN LA ROCHE (CH) 2012-11-07 EP disclosed
US-20100152190-A1 Substituted Pyrrolidine-2-Carboxamides F. HOFFMANN-LA ROCHE AG (CH) 2010-06-17 US disclosed
US-20100075948-A1 Substituted Pyrrolidine-2-Carboxamides DING QINGJIE 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152190-A1 Substituted Pyrrolidine-2-Carboxamides ARG2, CCNY, PYCR1 ADRB1 3449/4885ADRB3 3492/4885TDP1 1575/4885
US-20100075948-A1 Substituted Pyrrolidine-2-Carboxamides ARG2, CCNY, PYCR1 ADRB1 3449/4885ADRB3 3492/4885TDP1 1575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.